Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties.
about
Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapyTumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progeniesDetection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibodyAtypical cell populations associated with acquired resistance to cytostatics and cancer stem cell features: the role of mitochondria in nuclear encapsulationImmunocompetent murine models for the study of glioblastoma immunotherapyPreferential Association of Lissencephaly-1 Gene Expression with CD133+ Glioblastoma Cells.Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells.Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.Stem cells for ischemic brain injury: a critical review.Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms.CPEB1 modulates differentiation of glioma stem cells via downregulation of HES1 and SIRT1 expression.Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.Targeting stem cells-clinical implications for cancer therapy.Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.Principles of regulation of self-renewing cell lineages.Isolation, cultivation and identification of brain glioma stem cells by magnetic bead sortingBiological characteristics of a new human glioma cell line transformed into A2B5(+) stem cells.Endogenous brain pericytes are widely activated and contribute to mouse glioma microvasculature.Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.Evolutionary dynamics of feedback escape and the development of stem-cell-driven cancers.Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatmentCancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype.Contribution of microRNA-1275 to Claudin11 protein suppression via a polycomb-mediated silencing mechanism in human glioma stem-like cells.Active efflux of Dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly targeted agents.Nanog signaling in cancer promotes stem-like phenotype and immune evasionConstitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.De novo induction of genetically engineered brain tumors in mice using plasmid DNAEpigenetic gene regulation in stem cells and correlation to cancerTargeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.Immunological considerations of modern animal models of malignant primary brain tumors.FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.Circulating biomarker panels for targeted therapy in brain tumors.Identification of novel human leukocyte antigen-A*0201-restricted, cytotoxic T lymphocyte epitopes on CD133 for cancer stem cell immunotherapy.Enhanced Directional Migration of Cancer Stem Cells in 3D Aligned Collagen Matrices.How stemlike are sphere cultures from long-term cancer cell lines? Lessons from mouse glioma models.Id1 and NF-κB promote the generation of CD133+ and BMI-1+ keratinocytes and the growth of xenograft tumors in mice.Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells.Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.Immune and viral therapies for malignant primary brain tumors.Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?
P2860
Q21245716-1DFBA5E0-440D-40CE-AA2F-65BB7C9C7E92Q27318628-9BBF0BBE-8278-420B-BC98-BA1F8D5EBFF8Q30388310-A5DB8AAD-9417-43B9-8EA7-17132E738AEFQ30596704-52771468-79BC-476B-8386-49470115BA49Q33574853-A126E3A9-EB2E-464B-8203-5D669F78D790Q33776755-485998A1-5DF8-4667-9D61-C5D04E29B189Q33826808-99E80A57-B954-4F12-9071-6994FCE85D41Q33852195-14C8C1EB-A252-4E88-B32C-63DC734D237DQ33957236-175A7604-4A53-450F-8066-F662F684C8E3Q34154786-107E29A4-F189-41B0-909A-08A5C29B0A23Q34334389-18C96E95-F318-4CDD-92D0-DF6C57281D3AQ34500647-A9390EDE-85A5-4AB0-AB96-09B4BC7E9330Q34555251-93EE11DE-6EC2-4947-9E06-07F2F58937BDQ34630722-036FC21E-0E62-4D21-AB9C-A11B69236FFDQ34982740-A8C0D7A3-13C0-422F-994B-FC0799DA41DDQ35123782-781AE047-ACC1-4829-8BEF-8913DA6247A2Q35354646-829B7F47-D86E-472E-8935-F24F71F4BC22Q35392873-99B533E6-9B1B-4DA0-94E6-9C56A77CD3DCQ35521316-8B032693-3DA4-401C-A4F3-5A69E1AFB3BAQ35571371-5260488C-1D34-452B-9B2C-092F849D9DB8Q35832198-013AED61-4D22-4AD8-BC67-B968C013C919Q35871717-FE4E4830-2163-4A2B-8A31-98E06A9ED314Q36201775-241E7766-D7FB-4E9D-87F3-2200EFC8981BQ36312901-955E69B1-5DE6-420F-9C32-2D7710932C17Q36357895-88512F38-B237-4FE5-AF89-7F8D6BF5562FQ37151086-8212A50B-7C95-49AB-BA8B-8F11EDA31138Q37240292-CF6BF1DA-84CB-4FED-9570-6B572F415863Q37251747-C0667599-EA7A-4D71-9F1D-E354CA6CE796Q37532147-37BE79FC-2B65-493E-B83F-79C21DF130A6Q37611109-ACCEA963-81EE-4749-8DC1-19A9756E5F23Q37684595-5F98038B-8A46-49ED-9A3A-4651D9623FBCQ38252948-CA780735-1B26-4D5C-9707-A25C0BF4AB32Q38266427-D61713CC-36AB-4BEC-9F02-24E571AFE065Q38712173-97B4265D-F5DF-4F6A-89EA-9CC9AE1C2D4CQ38950033-D9A64B7C-1F3E-422A-8497-4A07812C4460Q39020692-630C14BE-3129-46E3-942D-238B1629649EQ39036703-942EED60-C42F-468F-90A9-0D935B1DFBA5Q39049644-B62C3D62-77F0-486E-9CC6-EFFFDFC06536Q39168899-68962B18-4BD6-4520-99E8-D1BB0D3507EDQ40905063-1F56C6C9-5945-4985-8645-14E3C18C336A
P2860
Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Persistence of CD133+ cells in ...... cer stem cell-like properties.
@ast
Persistence of CD133+ cells in ...... cer stem cell-like properties.
@en
Persistence of CD133+ cells in ...... cer stem cell-like properties.
@nl
type
label
Persistence of CD133+ cells in ...... cer stem cell-like properties.
@ast
Persistence of CD133+ cells in ...... cer stem cell-like properties.
@en
Persistence of CD133+ cells in ...... cer stem cell-like properties.
@nl
prefLabel
Persistence of CD133+ cells in ...... cer stem cell-like properties.
@ast
Persistence of CD133+ cells in ...... cer stem cell-like properties.
@en
Persistence of CD133+ cells in ...... cer stem cell-like properties.
@nl
P2093
P356
P1476
Persistence of CD133+ cells in ...... cer stem cell-like properties.
@en
P2093
John R Ohlfest
Katya Ericson
Paul E Champoux
Seunguk Oh
Stephen M Wiesner
Walter A Hall
Walter C Low
P304
P356
10.1089/SCD.2007.0133
P577
2008-02-01T00:00:00Z